Implementation of Pre-emptive Geno- and Phenotyping in 5-Fluorouracil- or Capecitabine-treated Patients
Status:
Not yet recruiting
Trial end date:
2021-09-30
Target enrollment:
Participant gender:
Summary
The aim of this study is to investigate if the systematic implementation of pre-emptive geno-
and phenotyping, and therefore a dose reduction based on the French guidelines and the
literature during the first month of treatment, reduces grade 3 or greater toxicity in
patients treated with 5-FU (5-fluorouracil) or capecitabine.
Therefore, a monocentric, partial prospective and partial retrospective trail was designed.